American Century Companies Inc Ligand Pharmaceuticals Inc Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, American Century Companies Inc holds 34,856 shares of LGND stock, worth $4.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,856

Previous 29,167 19.5%

Holding current value

$4.15 Million

Previous $2.46 Million 42.08%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$82.7 - $110.11 $470,480 - $626,415	5,689 Added 19.5%	34,856 $3.49 Million
Q2 2024 Aug 07, 2024	BUY	$68.53 - $87.91 $281,247 - $360,782	4,104 Added 16.37%	29,167 $2.46 Million
Q1 2024 May 14, 2024	BUY	$68.64 - $89.2 $412,389 - $535,913	6,008 Added 31.53%	25,063 $1.83 Million
Q4 2023 Feb 13, 2024	BUY	$49.57 - $72.63 $944,556 - $1.38 Million	19,055 New	19,055 $1.36 Million
Q3 2023 Nov 13, 2023	SELL	$58.86 - $72.67 $759,058 - $937,152	-12,896 Reduced 19.4%	53,575 $3.21 Million
Q2 2023 Aug 14, 2023	SELL	$69.53 - $79.33 $25,934 - $29,590	-373 Reduced 0.56%	66,471 $4.79 Million
Q1 2023 May 11, 2023	SELL	$65.67 - $77.08 $82,415 - $96,735	-1,255 Reduced 1.84%	66,844 $4.92 Million
Q4 2022 Feb 13, 2023	BUY	$61.72 - $96.74 $1.54 Million - $2.42 Million	24,969 Added 57.89%	68,099 $4.55 Million
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $431 - $4.64 Million	43,130 New	43,130 $3.71 Million
Q1 2022 May 11, 2022	SELL	$94.99 - $151.56 $151,604 - $241,889	-1,596 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$127.69 - $165.85 $15,578 - $20,233	122 Added 8.28%	1,596 $247,000
Q3 2021 Nov 10, 2021	BUY	$102.33 - $144.73 $150,834 - $213,332	1,474 New	1,474 $205,000
Q3 2019 Nov 13, 2019	SELL	$86.25 - $120.16 $2.05 Million - $2.85 Million	-23,716 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $24,697 - $29,748	-230 Reduced 0.96%	23,716 $2.71 Million
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $501,896 - $675,022	-4,738 Reduced 16.52%	23,946 $0
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $286,884 - $608,210	2,235 Added 8.45%	28,684 $3.89 Million
Q3 2018 Nov 02, 2018	BUY	$211.18 - $274.49 $394,695 - $513,021	1,869 Added 7.6%	26,449 $7.26 Million
Q2 2018 Aug 08, 2018	BUY	$150.77 - $207.98 $101,468 - $139,970	673 Added 2.82%	24,580 $5.09 Million
Q1 2018 May 03, 2018	BUY	$138.63 - $182.62 $523,189 - $689,207	3,774 Added 18.75%	23,907 $3.95 Million
Q4 2017 Feb 02, 2018	BUY	$128.36 - $147.04 $724,592 - $830,040	5,645 Added 38.96%	20,133 $2.76 Million
Q3 2017 Nov 01, 2017	BUY	$120.91 - $137.94 $1.75 Million - $2 Million	14,488	14,488 $1.97 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Ligand Pharmaceuticals Inc Transaction History